Total Funding
10
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 10 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
636048
Acton Pharmaceuticals is a specialty pharmaceutical company that develops and markets products for the treatment of respiratory conditions.
- Daniel Kreisler: President
- John Simon: CEO
About the Company
Acton Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on acquiring, developing and commercializing products primarily for the treatment of respiratory conditions.
The Company was founded by pharmaceutical executives experienced in respiratory product development and commercialization.
Acton is actively pursing the
acquisition of products in either late-stage clinical development or which are currently being marketed.


